Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC.LXRX · Entity 4970 | Director | June 03, 2026 | June 04, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LEXICON PHARMACEUTICALS, INC.
Report date June 03, 2026 · Filed June 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 89,312 |
Reported balance
After 2026-06-03 transaction · row 1
1 source rowRow 1 · 2026-06-03 · Exercise / conversion · Acquired 89,312 · Balance 89,312 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-06-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-03 · Exercise / conversion · Disposed 89,312 · Balance 0 F1: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2: Each restricted stock unit represents a contingent right to receive one share of common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date.
F2: Each restricted stock unit represents a contingent right to receive one share of common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 03, 2026 Filed Jun 4, 2026 20:12 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 89,312 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062822-26-000105 · form4.xml · derivative · entry 2 Cheung Ivan · CIK 0002042690 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 89,312 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 20:12 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 89,312 | $0.00 | $0.00 |
DisclosureSEC source: 0001062822-26-000105 · form4.xml · nonDerivative · entry 1 Cheung Ivan · CIK 0002042690 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,312 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2026 Filed May 4, 2026 20:30 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 43,478 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0001062822-26-000082 · form4.xml · derivative · entry 2 Cheung Ivan · CIK 0002042690 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,478 Underlying: Common Stock · 43,478 shares Expires 2036-05-01 F3 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| May 01, 2026 Filed May 4, 2026 20:30 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 35,714 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062822-26-000082 · form4.xml · derivative · entry 1 Cheung Ivan · CIK 0002042690 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,714 Underlying: Common Stock · 35,714 shares Expires not disclosed F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| June 03, 2025 Filed Jun 3, 2025 20:22 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 89,312 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-016471 · form4.xml · derivative · entry 2 Cheung Ivan · CIK 0002042690 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,312 Underlying: Common Stock · 89,312 shares Expires not disclosed F2 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| June 03, 2025 Filed Jun 3, 2025 20:22 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 103,806 | $0.00 Strike: $0.62 | $0.00 |
DisclosureSEC source: 0001127602-25-016471 · form4.xml · derivative · entry 1 Cheung Ivan · CIK 0002042690 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,806 Underlying: Common Stock · 103,806 shares Expires 2035-06-03 F1 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| December 02, 2024 Filed Dec 2, 2024 22:41 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 186,685 | $0.00 Strike: $0.80 | $0.00 |
DisclosureSEC source: 0001127602-24-028323 · form4.xml · derivative · entry 1 Cheung Ivan · CIK 0002042690 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 186,685 Underlying: Common Stock · 186,685 shares Expires 2034-12-02 F1 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.